Every 14 minutes, someone in the UK is diagnosed with a form of blood cancer.
Cure Leukaemia funds 15 specialist Research Nurses in the UK’s biggest cities as part of the Trials Accelerations Programme (TAP) Network. This network enables the accelerated setup, recruitment to and delivery of pioneering blood cancer clinical trials connecting patients from a catchment area of over 30 million people with potentially life-saving treatments not currently available through standard care.
Clinical trial set-up typically takes many years however the TAP Network makes it possible to set-up clinical trials in under a year, thus offering critically ill blood cancer patients an improved chance of survival.
Cure Leukaemia CEO James McLaughlin said: “We are immensely grateful for the support Gala Events have given the charity in recent years. Thanks to the support of organisations such as Gala Events, we have now expanded the TAP Network from 12 to 15 centres, increasing our geographical footprint and giving blood cancer patients a greater chance of survival across the country. We look forward to continuing our partnership with Gala Events to give patients hope and hasten global progress towards eradicating all forms of blood cancer within 25 years.”